Skip to main content

Advertisement

SpringerLink
Log in

Paraneoplastic Erythropoiesis in Patients With Ovarian Sertoli Leydig Cell Tumors: Retrospective Study From Tertiary Care Institute

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

A Correction to this article was published on 10 August 2022

This article has been updated

Abstract

To study the clinical, paraneoplastic hematological presentation of Sertoli Leydig cell tumor patients. This retrospective study involved women with Sertoli Leydig cell tumors treated at JIPMER from 2018 to 2021. We reviewed the hospital registry for the Sertoli Leydig cell tumor among all the ovarian tumors being treated in the department of obstetrics and gynecology. We retrieved the datasheets of patients with Sertoli Leydig cell tumor and studied their clinical and hematological presentation, their management, complications, and follow-up. We had 5 patients of Sertoli Leydig cell tumor of 390 ovarian tumors operated during the study period. The mean age at presentation was 31.6 years. All 5 patients had hirsutism and menstrual irregularity. One patient presented with symptoms of polycythemia along with these complaints. Elevated serum testosterone was seen in all (mean being 688 ng/ml). Mean preoperative hemoglobin was 15.84%, and mean hematocrit was 50.14%. Fertility-sparing surgery was performed in 3 of them and the rest had complete surgery. All patients were in Stage IA. Histologically, one had Pure Leydig cell, three had steroid cell tumor not otherwise specified and one was mixed Sertoli Leydig cell tumor. After the operation, the hematocrit and testosterone levels came down to the normal range. The virilizing manifestations regressed over 4–6 months. With a follow-up period ranging from 1 to 4 years, all 5 patients are alive, one patient had a disease recurrence in the ovary after 1 year of primary surgery. She is disease-free following the second surgery. The rest of the patients had no disease recurrence and are disease-free following surgery. Virilizing ovarian tumors can have paraneoplastic polycythemia which needs to be looked into while evaluating these patients. Similarly, while evaluating polycythemia in young females, an androgen-secreting tumor has to be ruled out as it is reversible and completely treatable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Image I
Image II
Image III
Image IV

Similar content being viewed by others

Change history

References

  1. Pugeat M, Raverot G, Plotton I, Brac de la Perrière A, Mirakian P, Déchaud H, Berger N, Peix JL (2006) Androgen-secreting adrenal and ovarian neoplasms. InAndrogen excess disorders in women. Humana Press, pp 75–84

  2. Young R, Scully R (2008) Sex cord-stromal. Steroid cell, and germ cell tumors of the ovary glob. libr. women's med.,(ISSN: 1756–2228)

  3. Al Harbi R, McNeish IA, El-Bahrawy M (2021) Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management. Int J Gynecol Cancer Off J Int Gynecol Cancer Soc 31(2):161–168

    Article  Google Scholar 

  4. Tandon R, Goel P, Saha PK, Takkar N, Punia RP (2007) A rare ovarian tumor–Sertoli-Leydig cell tumor with heterologous element. Medscape Gen Med 9(4):44

    Google Scholar 

  5. Cai S-Q, Zhao S-H, Qiang J-W, Zhang G-F, Wang X-Z, Wang L (2013) Ovarian Sertoli-Leydig cell tumors: MRI findings and pathological correlation. J Ovarian Res 26(6):73

    Article  Google Scholar 

  6. Abu-Zaid A, Azzam A, Alghuneim LA, Metawee MT, Amin T, Al-Hussain TO (2013) Poorly differentiated ovarian Sertoli-Leydig cell tumor in a 16-year-old single woman: a case report and literature review. Case Rep Obstet Gynecol 2013:858501

    PubMed  PubMed Central  Google Scholar 

  7. Tandon R, Goel P, Kataria S, Saha PK, Punia RPS, Dimri K (2014) Paraneoplastic erythrocytosis in a malignant ovarian steroid cell tumor. Indian J Hematol Blood Transfus Off J Indian Soc Hematol Blood Transfus 30(1):54–55

    Article  Google Scholar 

  8. Yetkin DO, Demirsoy ET, Kadioglu P (2011) Pure leydig cell tumour of the ovary in a post-menopausal patient with severe hyperandrogenism and erythrocytosis. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 27(4):237–240

    Article  CAS  Google Scholar 

  9. Kozan P, Chalasani S, Handelsman DJ, Pike AH, Crawford BA (2014) A Leydig cell tumor of the ovary resulting in extreme hyperandrogenism, erythrocytosis, and recurrent pulmonary embolism. J Clin Endocrinol Metab 99(1):12–17

    Article  CAS  PubMed  Google Scholar 

  10. Means Jr RT, Brodsky RA, Kunins L (2021) Diagnostic approach to anemia in adults. UpToDate; c2021.[cited 2021 Nov 2]. Available from https://www.uptodate.com/contents/diagnostic-approach-to-anemia-in-adults.

  11. Yao Q, Zhou G, Xu M, Dai J, Qian Z, Cai Z, Zhang L, Tan Y, Hu R (2019) Blood metal levels and serum testosterone concentrations in male and female children and adolescents: NHANES 2011–2012. PLoS One 14(11):e0224892

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Handelsman DJ (2020) Androgen physiology, pharmacology, use and misuse. Endotext [Internet]

  13. Fernández-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ et al (2010) Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab 95(6):2560–2575

    Article  PubMed  Google Scholar 

  14. Ovarian Cancer Continue Including Fallopian Tube Cancer and Primary Peritoneal Cancer Version 1.2022 — January 18, 2022 NCCN.org

  15. Siekierska-Hellmann M, Sworczak K, Babińska A, Wojtylak S (2006) Ovarian thecoma with androgenic manifestations in a postmenopausal woman. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 22(7):405–408

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecology, JIPMER, Pondicherry, India

    Arpitha Anantharaju, Baishali Roy, Kirti Girish Deodhare & Parvathi Naik

  2. Department of Pathology, JIPMER, Pondicherry, India

    Bheemanathi Hanuman Srinivas & Bhavana Ashok Bade

Authors
  1. Arpitha Anantharaju
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Baishali Roy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kirti Girish Deodhare
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bheemanathi Hanuman Srinivas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bhavana Ashok Bade
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Parvathi Naik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Parvathi Naik.

Ethics declarations

Ethical Approval

The study is approved by the Institutional research board.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original version of this article was revised. Image 1 to 4 are now added.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anantharaju, A., Roy, B., Deodhare, K.G. et al. Paraneoplastic Erythropoiesis in Patients With Ovarian Sertoli Leydig Cell Tumors: Retrospective Study From Tertiary Care Institute. Indian J Surg Oncol 14, 497–503 (2023). https://doi.org/10.1007/s13193-022-01585-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-022-01585-9

Keywords

Search

Navigation